Your session is about to expire
← Back to Search
Lifestyle Intervention for Preconception Care in Overweight Women
N/A
Recruiting
Led By William D Fraser, MD,MSc
Research Sponsored by Université de Sherbrooke
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Woman's body mass index ≥ 25 kg/m2
Be between 18 and 65 years old
Must not have
Prior bariatric surgery
Type 1 or 2 diabetes mellitus
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 0, 2, 4, and 6 months in preconception and 10-12 weeks, 24-26 weeks, and 32-34 weeks in pregnancy.
Awards & highlights
No Placebo-Only Group
Summary
This trial will help researchers understand if a combination of motivational interviewing and mobile phone follow-ups can help overweight women and their partners adopt healthier lifestyle habits before conception. Additionally, the study will evaluate the impact of the intervention on weight, waist circumference, and body fat percentage of the participants.
Who is the study for?
This trial is for overweight women with a BMI of ≥25 kg/m2 who plan to conceive within the next year, and their partners. They must have access to a smartphone but can't join if they have diabetes, prior weight loss surgery, or conditions affecting weight significantly. Women with infertility issues, eating disorders, or contraindications to pregnancy or exercise are also excluded.
What is being tested?
The study tests whether motivational talks and a mobile app can help couples adopt healthier habits before pregnancy. It tracks changes in women's and partners' weight and body fat. The impact on pregnancy outcomes like complications, delivery mode, and baby's birth weight will be evaluated.
What are the potential side effects?
Since this is a lifestyle intervention involving dieting advice and physical activity rather than medication or medical procedures, side effects may include typical reactions to new exercise routines such as muscle soreness or fatigue.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
My BMI is 25 or higher.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I have had weight loss surgery in the past.
Select...
I have type 1 or type 2 diabetes.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 0, 2, 4, and 6 months in preconception and 10-12 weeks, 24-26 weeks, and 32-34 weeks in pregnancy.
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~0, 2, 4, and 6 months in preconception and 10-12 weeks, 24-26 weeks, and 32-34 weeks in pregnancy.
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Women's diet quality in preconception measured with the Canadian-Healthy Eating Index- 2007
Secondary study objectives
Men and Women's Anxiety and Depression symptoms measured with the Hospital Anxiety and Depression Scale.
Men and Women's Sleep quality measured with the Pittsburgh Sleep Quality Index
Men and Women's diet quality measured with the Canadian-Healthy Eating Index- 2007.
+12 moreOther study objectives
Fertility outcomes
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Group I: InterventionExperimental Treatment1 Intervention
Healthy for my Baby Intervention
Group II: ControlExperimental Treatment1 Intervention
Usual care
Find a Location
Who is running the clinical trial?
Université de SherbrookeLead Sponsor
307 Previous Clinical Trials
77,556 Total Patients Enrolled
1 Trials studying Preconception Care
50 Patients Enrolled for Preconception Care
William D Fraser, MD,MScPrincipal InvestigatorResearcher, Centre de recherche du CHUS
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have had weight loss surgery in the past.My BMI is 25 or higher.I have type 1 or type 2 diabetes.I or my partner plan to try for a baby within the next year.I expect to lose a lot of weight due to my condition or upcoming surgery.
Research Study Groups:
This trial has the following groups:- Group 1: Control
- Group 2: Intervention
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.